Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial bioenergetics and neuroprotective pathways refer to the complex network of biochemical processes responsible for energy production and cellular maintenance within neurons. These pathways center on the mitochondrial electron transport chain's ability to generate adenosine triphosphate (ATP) while managing the production of reactive oxygen species (ROS). In many neurodegenerative conditions, mitochondrial dysfunction leads to energy failure, oxidative stress, and the activation of pro-apoptotic signaling, resulting in neuronal loss. Therapeutic strategies in this area focus on preserving mitochondrial integrity, enhancing metabolic efficiency, and activating endogenous protective mechanisms like the Nrf2 pathway or sirtuins. Because this term describes a broad set of physiological processes rather than a single molecular entity, it is classified as a pathway or therapeutic area rather than a specific drug target.
Drugs targeting these pathways typically aim to enhance ATP production, stabilize the mitochondrial membrane potential, or reduce the production of reactive oxygen species (ROS) to prevent neuronal death.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial bioenergetics and neuroprotective pathways.